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Abstract
The balanced turnover of collagen is necessary to maintain the mechanical strength of pelvic supportive connective tissues. Homeobox (HOX)
A11 is a key transcriptional factor that controls collagen metabolism and homoeostasis in the uterosacral ligaments (USLs), and the deficient
HOXA11 signalling may contribute to alterations in the biochemical strength of the USLs, leading to pelvic organ prolapse (POP). However, it is
unknown how HOXA11 transcripts are regulated in the USLs. In this study, we found that microRNA (miRNA)-30d and 181a were overexpres-
sed in women with POP, and their expression was inversely correlated with HOXA11 mRNA levels. The overexpression of miR-30d or 181a sup-
pressed HOXA11 mRNA and protein levels in 293T cells, whereas the knockdown of these miRNAs enhanced HOXA11 levels and collagen
production. Cotransfection of a luciferase reporter plasmid containing the 30-untranslated region of HOXA11 with miR-30d or 181a mimic
resulted in decreased relative luciferase activity. Conversely, cotransfection with anti-miR-30d or 181a increased luciferase activity. Taken
together, these results indicate that both miR-30d and 181a are important posttranscriptional regulators of HOXA11 in the USLs and could be a
potential therapeutic target for POP.
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Introduction
Pelvic organ prolapse (POP) is the downward descent of pelvic
organs that results in a protrusion of the vagina, uterus or both. While
not life-threatening, it often causes bladder, bowel and pelvic symp-
toms that can have an adverse effect on a woman’s daily activities
and quality of life [1]. POP is also a significant economic burden to
women and healthcare systems. It affects almost half of all women
over 50 years of age [2], and one in five women will undergo surgery
for POP in their lifetime [3]. In the United States, the direct cost of
prolapse surgery is greater than 1 billion dollars per year [4], and as
the population is ageing, the demand for POP care is estimated to
double over the next 40 years [5].
Nonetheless, relatively little is known about the underlying patho-
physiology of POP. Although several factors, including advancing
age, vaginal childbirth and obesity, have been implicated as the risk
factors, they do not fully explain the development of POP. It has been
proposed that the biomechanical weakness of pelvic floor supportive
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structures, compounded by the risk factors cited above, leads to POP
[1]. Moreover, the need to improve treatment strategies is highlighted
by the high failure rate after surgery, and this is related to the poor
quality of pelvic supportive tissues [6]. Therefore, the identification
of critical molecular pathways involved in the attenuation of pelvic
supportive tissues is essential for developing effective prevention and
treatment strategies for POP.
Recently, Homeobox (HOX) A11 has attracted great attention for
its role in the development and maintenance of the uterosacral liga-
ments (USLs), the main supportive structure of the uterus and upper
vagina. Targeted deletion of this gene in HOXA11 null-mutant mice
resulted in the lack of the USLs [7]. In another murine model, repres-
sion of HOXA11 by vectors bearing HOXA11 short hairpin RNA led to
the attenuation of the USLs, concomitant with changes in collagen
metabolism favouring catabolism over synthesis [8]. HOXA11 has
also been reported to promote the proliferation of fibroblasts, the
major cell type that produces collagen, in vitro [9]. Thus, HOXA11 is
now characterized as a key upstream transcriptional factor that con-
trols collagen metabolism and homoeostasis in the USLs, and the
deficient HOXA11 signalling may contribute to alterations in the bio-
chemical strength of the USLs, leading to POP [7–9]. However, it is
unknown how HOXA11 transcripts are regulated in the USLs.
MicroRNAs (miRNAs) are small (~22 nucleotides), endogenous
RNA molecules that play important regulatory roles by targeting
mRNAs for cleavage or translational repression. Although miRNA
genes represent nearly 1% of the genome, it is estimated that ~30%
of the protein-encoding genes are regulated by at least one miRNA
[10, 11]. They play key roles in diverse regulatory pathways including
developmental processes, cell growth, differentiation and apoptosis
[12], and it has been reported that aberrant miRNA expression is
associated with various human diseases [13, 14]. However, the role
of miRNAs in the pathogenesis of POP has not been addressed. Con-
sidering the emerging evidence showing that miRNAs regulate several
other HOX genes [15], aberrantly expressed miRNAs may contribute
to the development of POP by modulating the expression of HOXA11.
To test this hypothesis, we selected miRNAs based on microarray
and a bioinformatic approach [16], and then verified their expressions
and the correlation with HOXA11 expression in the tissues using fur-
ther quantitative real-time PCR (qRT-PCR) analysis. We also per-
formed a series of functional studies to determine the role of those
miRNAs in the regulation of HOXA11.
Materials and methods
Tissue collection
All experiments were performed following the approval of the review
board for human research of Seoul National University Hospital
(H-1302-087-466), and informed consent was obtained from all of the
participating women. Prior to surgery, a pelvic examination using the
POP-quantification system was performed to evaluate the presence of
POP. Data regarding age, vaginal parity, body mass index, menopausal
status and prior prolapse surgery were also recorded. Menopause was
defined as the cessation of menses for at least 1 year.
The patient group consisted of 38 women who underwent hysterec-
tomy with sacrocolpopexy for symptomatic POP that was stage II or
greater. The control group consisted of 38 age-matched women with
POP-quantification stage 0 or I who received operations for benign
gynaecological indications (i.e. leiomyoma, adenomyosis, endometrial
hyperplasia, carcinoma in situ of the uterine cervix). There were no dif-
ferences in mean age, vaginal parity, body mass index or menopausal
status between the two groups (Table 1). None of the postmenopausal
women in either group were undergoing hormone replacement therapy.
At the time of surgery, USL samples 1 9 1 cm in size were collected
from the area of insertion into the cervix, a location where the ligament
is consistently identifiable. The samples were immediately snap frozen
in liquid nitrogen and kept at 80°C until RNA extraction was per-
formed. From each group, eight samples were used for microarray, and
the remaining 30 samples were used for qRT-PCR validation.
MiRNA microarray
MiRNAs were extracted using the mirVana miRNA isolation kit (Ambion,
Austin, TX, USA) according to the manufacturer’s protocols. Purified
miRNAs were labelled using the mirVana miRNA Array Labeling kit and
coupled to the Cy5 Post-Labeling Reactive Dye (Amersham, GE Health-
care Bio-Sciences, Piscataway, NJ, USA). The labelled samples were
washed and hybridized in duplicate to mirVana miRNA Bioarrays (Ambi-
on) using the mirVana miRNA Bioarray Essentials kit. Fluorescence
intensities were processed and measured using the GeneChip scanner
3000 7G (Agilent Technologies, Santa Clara, CA, USA). The levels of
miRNA hybridization were determined using GenePix Pro 6.0 software
as recommended by the manufacturer. The background-adjusted intensity
Table 1 Clinical characteristics of enrolled women with and without
POP
Patient
(n = 38)
Control
(n = 38)
P-value
Age (year), mean  SD 56.0  9.5 54.1  7.9 0.35
Vaginal parity, median
(IQR)
2 (1) 2 (1) 0.21
BMI (kg/m2),
mean  SD
24.8  3.0 24.4  3.3 0.66
Menopause, n (%) 26 (68.4) 21 (55.3) 0.24
Prior prolapse surgery,
n (%)
0 0 NA
POP-Q stage, n (%)
0–I 0 38 (100) <0.01
II 10 (26.3) 0
III 20 (52.6) 0
IV 8 (21.1) 0
POP, pelvic organ prolapse; SD, standard deviation; IQR, interquartile
range; BMI, body mass index; NA, not applicable; POP-Q, pelvic organ
prolapse-quantification.
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for each miRNA was subjected to a global variance stabilization normali-
zation procedure. MiRNAs were considered to be overexpressed only if
the differences were determined to be significant by a two-sample t-test
(P < 0.05) and on average showed at least a 1.5-fold increase in patient
samples compared with matched controls. Heatmap analysis and hierar-
chical clustering were performed with R project software.
Cell culture
293T cells, derived from human embryonic kidney, were purchased
from the American Type Culture Collection (Manassas, VA, USA) and
maintained in DMEM (Sigma-Aldrich, St Louis, MO, USA), containing
10% foetal bovine serum without antibiotics-antimycotics, at 37°C in a
humidified 5% CO2 incubator until the cells reached 40–50% conflu-
ence. Culture media were replaced with fresh media every 2–3 days.
The cells were used between passages 5 and 10.
Transfection experiments
293T cells were plated at a cellular density of 1 9 106 per well on 100-
mm culture dishes and cultured overnight. The cells were then trans-
fected with double-stranded RNA oligos comprising the mature miRNA
(miRNA mimic), RNA oligonucleotides complementary to mature miRNA
(anti-miRNA) or negative controls (miRNA mimic, anti-miRNA negative
control; GenePharma Co., Ltd, Shanghai, China) at a final concentration
of 100 nM with the use of Lipofectamine RNAiMAX reagent (Invitrogen,
Carlsbad, CA, USA). At 48 hrs after transfection, cellular lysates were
collected for RNA or protein isolation. The transfection efficiency was
~80%, as measured by the uptake of a FAM-labelled negative control.
qRT-PCR analysis
Total RNA was extracted using the mirVana miRNA isolation kit (Ambion),
and then cDNA was generated using the GoScript RT system (Promega,
Madison, WI, USA) according to the manufacturer’s protocol. qRT-PCR for
indicated genes was performed in a reaction mixture containing SYBR Pre-
mix Ex Taq (TaKaRa, Tokyo, Japan). PCR primer sequences were HOXA11,
forward 50-GTACTTACTACGTCTCGGGTCCAG-30 and reverse 50-AGTCTCT-
GTGCACGAGCTCCT-30; and b-actin, forward 50-CGTACCACTGGCATCT-
GAT-30 and reverse 50-GTGTTGGCGTACAGGTCTTTG-30. The reaction
mixtures were preincubated at 95°C for 5 sec. followed by 40 cycles of
denaturation at 95°C for 5 sec., annealing at 60°C for 34 sec. and exten-
sion at 95°C for 15 sec., 60°C for 1 min. and 95°C for 15 sec. The quan-
tification of miRNAs was carried out using TaqMan miRNA assays
(Applied Biosystems, Carlsbad, CA, USA) according to the manufacturer’s
protocol. The samples were analysed with the 7500 real-time PCR system
(Applied Biosystems). All PCRs were performed in triplicate, and the
specificity of each reaction was determined by melting curve analysis at
the dissociation stage. For relative quantification, the data were analysed
using the 2DDCt method, where b-actin and U6B were used as internal
controls for HOXA11 and miRNAs, respectively.
Western blot analysis
Cells were lysed in 200 ll of RIPA buffer [150 mM NaCl, 1% NP-40,
0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate, 50 mM
Tris-HCl (pH 8.0), 100 mM PMSF] with a protease inhibitor and
centrifuged at 14,000 9 g for 10 min. at 4°C. The proteins in the
supernatant were mixed with denaturing sample buffer (1:1) and boiled
for 5 min. at 94°C. Equal amounts of protein (30 lg) were loaded and
separated by 10% SDS-PAGE and blotted onto nitrocellulose mem-
branes (Bio-Rad, Hercules, CA, USA). The membranes were blocked
with TBST containing 5% nonfat dry milk for 1 hr at 4°C and incubated
with anti-HOXA11 (1:1,000; Abcam, Cambridge, UK), COL1A2 (1:500;
Abcam), or COL3A1 (1:500; Sigma-Aldrich) antibodies overnight at 4°C.
An anti-b-actin antibody (1:5,000; Sigma-Aldrich) was used as a con-
trol. After washing in TBST, the membranes were incubated with horse-
radish peroxidase-conjugated secondary antibodies (Abcam) for 1 hr at
4°C and washed again in TBST. The signal was detected using an
enhanced chemiluminescence kit (Thermo Scientific, Rockford, IL, USA)
and the intensity was quantified using ImageJ software.
Luciferase reporter assay
To validate the HOXA11 30-untranslated region (UTR) as a target of
miR-30d and 181a, in vitro assays using the miTarget miRNA 30-UTR
target clones (HmiT008983-MT01; Genecopoeia, Rockville, MD, USA)
were performed. These miRNA target clones consisted of the pEZX-
MT01 vector containing the coding sequences of both firefly and Renilla
luciferase and the full 30-UTR of the HOXA11 transcript (accession num-
ber: NM_005523.5) inserted downstream of the firefly luciferase
sequence. According to TargetScan (www.targetscan.org), the binding
sites of miR-30d and 181a are predicted to be located at positions
1173 to 1180 and 1219 to 1226, respectively. For mutagenesis assays,
these two miRNA-binding sites within the 30-UTR of the HOXA11 tran-
script were deleted. After heat-shock transformation in competent Esc-
herichia coli cells (One Shot TOP 10 competent cells; Invitrogen), the
plasmids were amplified in Luria–Bertani medium supplemented with
50 lg/ml kanamycin (Bio Basic Inc., Markham, ON, Canada). Plasmid
DNA was prepared on columns (NucleoBond PC 500; Macherey-Nagel,
D€uren, Germany). The identity of the amplified plasmids was confirmed
by capillary sequencing (ABI 3730XL; Applied Biosystems) using the
sequencing primers 50-GATCCGCGAGATCCTGAT-30 (forward) and
50-CCTATTGGCGTTACTATG-30 (reverse).
293T cells were plated (1 9 104/well) in 96-well plates. A total of
100 ng of plasmid DNA was cotransfected with miRNA mimic, anti-miR-
NA or negative controls as described above. Luciferase assays were
performed 48 hrs after transfection using the dual-luciferase reporter
assay system (Promega). Firefly luciferase activity was normalized to
Renilla luciferase expression for each sample. Each experiment was
conducted in triplicate.
Statistical analysis
Statistical analyses were performed with SPSS 19.0 for Windows
(SPSS, Chicago, IL, USA). The normality of the data was assessed
using the Shapiro–Wilk test. Comparisons between two groups were
performed with the two-sample t-test or the Mann–Whitney U-test for
continuous variables and the chi-squared test for categorical variables.
For comparisons among >2 groups, one-way ANOVA was performed, and
Dunnett’s procedure was used for multiple comparisons. Correlation
analyses were performed with Pearson’s correlation analyses. All of the
statistical tests were two-tailed, and P-values less than 0.05 were con-
sidered statistically significant.
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Results
The expression of miR-30d and miR-181a is
significantly increased in the USLs of POP
patients and is inversely correlated with HOXA11
expression
In an attempt to identify miRNAs involved in HOXA11 regulation, we
first compared miRNA expression profiles in the USLs of POP
patients and controls using microarray. The miRNAs that were over-
expressed differentially in POP patients included miR-222, miR-720,
miR-1260a, miR-1260b, miR-99b, miR-3653, miR-92a, miR-423,
miR-30d, miR-130b, miR-3607, miR-4286, miR-140, miR-181c, miR-
1274a, miR-342, miR-151a and miR-181a (Fig. 1A, Table 2). Then
we searched miRNAs that could regulate HOXA11 using biocomputa-
tional prediction algorithms from three different programs (miRanda,
TargetScan and PicTar). This approach is known to provide a good
balance of sensitivity and specificity and reduce the risk of predicting
false positive targets [17]. Approximately ten miRNAs were identified
as potentially targeting HOXA11 mRNA. The two most notable miRNAs
were miR-30d and 181a, which were also significantly overexpressed
in the microarray. The alignment of the 30-UTR of HOXA11 among a
wide range of species revealed that the predicted binding sites for miR-
30d and 181a are highly conserved during evolution, suggesting the
potential importance of these binding sites in HOXA11 (Fig. 2).
Next, we performed further qRT-PCR analyses for the remaining
samples not used in the microarray analysis to investigate the levels
of miR-30d, miR-181a and HOXA11 mRNA expression and the corre-
lation between these miRNAs and HOXA11 expression. Compared to
controls, the expression levels of miR-30d and 181a were signifi-
cantly increased in POP patients, whereas HOXA11 mRNA expression
was significantly decreased (Fig. 1B). In addition, there were signifi-
cant inverse correlations between the expression of miR-30d or
181a and HOXA11 mRNA expression (Pearson correlation coeffi-
cient = 0.78 and 0.73, respectively; P < 0.01). However, we did
not find any significant POP-Q stage-related correlation or difference
in the expression levels of miR-30d, miR-181 and HOXA11 among
POP patients (P > 0.05).
A
B
Fig. 1MiRNA expression profiles in the
USLs. Microarray revealed that eighteen
miRNAs were overexpressed in POP
patients compared with controls (n = 8/
group), as shown in the form of heatmaps
(A). qRT-PCR analyses of two miRNAs
and HOXA11 expression in the USLs (B).
The expression of miR-30d and 181a was
significantly increased in women with POP
(n = 30) compared to controls, whereas
HOXA11 mRNA expression was signifi-
cantly decreased in POP patients versus
controls (n = 30/group). Quantitative data
representing the mean  SD are pre-
sented in the bar graph. *P < 0.01 com-
pared with expression in the USLs from
the controls.
504 ª 2015 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Both miR-30d and miR-181a regulate HOXA11
mRNA and protein levels
We performed a series of functional studies to determine the role of
miR-30d and 181a in the regulation of HOXA11. First, whether the
overexpression of miR-30d or 181a was sufficient to repress HOXA11
levels was tested. These miRNAs were overexpressed using specific
miRNA mimics. qRT-PCR showed that the expression of miR-30d
and 181a was significantly increased (Fig. 3A and B), and this
repressed endogenous HOXA11 mRNA and protein levels in 293T
cells (Fig. 3C). Next, cultured 293T cells were transfected with
Table 2 Highly overexpressed miRNAs in the USLs of women with POP
miRNA Patients (mean  SD) Controls (mean  SD) Fold change P-value
miR-222 8.81  0.73 7.87  0.53 1.91 0.01
miR-720 15.12  0.55 14.21  0.51 1.87 <0.01
miR-1260b 11.91  0.38 11.02  0.38 1.85 <0.01
miR-1260a 12.76  0.57 11.96  0.36 1.75 <0.01
miR-99b 9.44  0.48 8.65  0.55 1.74 <0.01
miR-3653 9.09  0.56 8.31  0.43 1.72 <0.01
miR-92a 10.63  0.46 9.93  0.43 1.62 <0.01
miR-423 8.38  0.59 7.68  0.29 1.61 0.01
miR-30d 10.43  0.30 9.74  0.59 1.61 0.01
miR-130b 7.05  0.37 6.39  0.59 1.58 0.02
miR-3607 6.41  0.32 5.74  0.52 1.58 0.01
miR-4286 13.36  0.41 12.70  0.53 1.58 0.02
miR-140 11.18  0.40 10.55  0.56 1.55 0.02
miR-181c 6.46  0.44 5.83  0.51 1.55 0.02
miR-1274a 11.61  0.39 10.98  0.46 1.55 0.01
miR-342 10.11  0.36 9.49  0.48 1.52 0.01
miR-151a 8.66  0.25 8.07  0.45 1.51 <0.01
miR-181a 9.11  0.27 8.52  0.45 1.50 <0.01
miRNA, microRNA; USL, uterosacral ligament; POP, pelvic organ prolapse.
Fig. 2 Sequence alignment between miR-
30d or 181a and the 30-UTR of HOXA11
in several species. The seed sequences of
HOXA11 30-UTR targeted by miR-30d and
181a are highly conserved across species
(from TargetScan). The number repre-
sents the position of the ‘seed region’
matched to miR-30d and 181a within the
UTR sequences. Hsa, human; Ptr, chim-
panzee; Mml, rhesus; Oga, bushbaby; Tbe,
treeshrew, Mmu, mouse; Rno, rat; Cpo,
guinea pig; Ocu, rabbit; Cfa, dog; Fca, cat;
Eca, horse; Bta, cow; Laf, elephant; Mdo,
opossum; Oan, platypus.
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anti-miR-30d, anti-miR-181a or a negative control. The successful
knockdown of these miRNAs in the 293T cells was confirmed (Fig. 3A
and B) and demonstrated that the knockdown of miR-30d or 181a
enhances HOXA11 mRNA and protein levels, which was accompanied
by increased production of collagen type I and III proteins (Fig. 3D
and E).
HOXA11 is a direct target of miR-30d and
miR-181a
The above findings suggest that HOXA11 is regulated by miR-30d
and 181a in the USLs. However, the regulation of HOXA11 by
these miRNAs may be indirect. To assess whether miR-30d and
181a can directly alter the expression of HOXA11, a luciferase
expression plasmid containing the full-length 30-UTR of HOXA11
transcript was transfected into 293T cells. Cotransfection of this
luciferase expression plasmid with miR-30d or 181a mimic, but
not a negative control, resulted in a significant decrease in
relative luciferase activity. In addition, the deletion of these two
miRNA-binding sites completely abolished miR-30d- and 181a-
mediated repression, demonstrating the specificity of repression
(Fig. 4A).
Because miR-30d and 181a mimics could inhibit HOXA11 30-UTR
luciferase activity, inhibitors to these two miRNAs were assessed to
determine if they could exert the opposite effect. Not surprisingly, co-
transfection with anti-miR-30d or 181a significantly increased the rel-
ative luciferase activity (Fig. 4B). Taken together, these results show
that both miR-30d and 181a can directly influence HOXA11 through
specific binding to its 30-UTR.
A B
C
E
D
Fig. 3 Effects of the overexpression and
knockdown of miR-30d or 181a on the
expression of HOXA11. qRT-PCR analysis
for miR-30d (A) or 181a (B) in 293T cells
transfected with a specific miRNA mimic
or anti-miRNA, indicating the successful
overexpression or knockdown. Trans-
fection with miR-30d or 181a mimic
decreased HOXA11 mRNA and protein lev-
els (C). Conversely, transfection with anti-
miR-30d or 181a resulted in an increase
in HOXA11 levels (D) and collagen pro-
duction (E). Each experiment was con-
ducted in triplicate. Quantitative data
representing the mean  SD are pre-
sented in the bar graph. *P < 0.01,
†P < 0.05 compared with negative con-
trols. Note that the left and right graph on
E have different scales on the Y-axis.
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Discussion
Pelvic floor connective tissues (endopelvic fascia and ligaments) are
critical structures that support pelvic organs, along with the levator
muscles. They are composed of abundant extracellular matrix, where
collagen comprises a large proportion and is responsible for confer-
ring structural integrity and tensile strength [18]. Tissue remodelling
is a dynamic process, and therefore the balanced turnover of collagen
is necessary to maintain the mechanical strength of the tissue. How-
ever, previous biochemical studies have demonstrated a decrease in
collagen content in the pelvic supportive connective tissues of women
with POP compared to women without POP, and this is related to
decreased synthesis and increased breakdown by matrix metallopro-
teinase as well as decreased cellularity, specifically, of fibroblasts
[9, 19–21]. Thus, reversal of this process represents an important
therapeutic target in POP management.
Given its vital role in the control of collagen metabolism and cell
proliferation [7–9], HOXA11 may serve as a good candidate for the
maintenance of collagen homoeostasis in the USLs. HOX genes are
predominantly expressed during embryonic development, but also
continued expression of HOXA cluster genes is observed in the adult
female reproductive tracts [22]. However, the expression of HOXA11
mRNA and protein is significantly decreased in the USLs of women
with POP [7, 9]. As a plausible posttranscriptional regulator, we try to
identify the specific miRNAs involved in the regulation of HOXA11.
Here, we provide several lines of evidence to show that the expres-
sion of HOXA11 in USLs is regulated by two miRNAs, miR-30d and
miR-181a. First, miR-30d and 181a are overexpressed in women with
POP compared to women without POP, and the expression of both
miRNAs is inversely correlated with HOXA11 mRNA expression. Sec-
ond, the overexpression of miR-30d or 181a suppresses HOXA11
mRNA and protein levels in 293T cells, whereas the knockdown of
these miRNAs enhances HOXA11 levels and collagen production.
Third, these miRNAs can directly influence mRNA levels through
specific binding to the 30-UTR of HOXA11. Taken together, these
results indicate that both miR-30d and 181a are important posttran-
scriptional regulators of HOXA11 and the overexpression of these
miRNAs may be a hidden mechanism of the deficient HOXA 11 signal-
ling in the USLs associated with POP.
Because each miRNA can bind and regulate multiple mRNA targets
[11], the aberrant expression of these miRNAs may also contribute to
the pathogenesis of POP through pathways other than the dysregula-
tion of HOXA11. For example, connective tissue growth factor, a pow-
erful inducer of extracellular matrix synthesis, is known to be a target
of miR-30 family [16]. Therefore, miR-30d overexpression may limit
collagen synthesis by inhibiting the expression of connective tissue
growth factor as well as HOXA11. In addition, both miR-30d and 181a
are known to play an important role in cellular apoptosis. MiR-30d
functions as a proapoptotic inducer [23], and miR-181a directly
repress the expression of B cell lymphoma-2 (Bcl-2), an anti-apoptotic
protein that interacts with mitochondria [24, 25], thereby promoting
cellular apoptosis. Notably, increased mitochondrial apoptosis and
decreased Bcl-2 expression have been reported in the pelvic support-
ive tissues of POP patients [26, 27]. The overexpression of miR-30d
and 181a may underlie these changes. The broad effects of miR-30d
and 181a in targeting several genes that affect collagen homoeostasis
imply that a therapeutic approach to decrease miR-30d and 181a
might be beneficial to prevent or restore the decrease in collagen con-
tent within the USLs, as revealed by this study.
Although this study suggests key roles for miR-30d and 181a in
the control of HOXA11 expression, the overexpression of these miR-
NAs may not fully explain the decreased HOXA11 expression that is
observed in the USLs of women with POP. It is important to note that
a direct one-to-one stoichiometric relationship between the levels of
miR-30d or 181a and HOXA11 expression does not exist. In the
experiments involving the overexpression and knockdown of miR-
30d or 181a, the magnitude of the changes in HOXA11 expression
was modest compared with the changes in the expression of these
miRNAs, suggesting that they are not the sole determinants of
A B
Fig. 4 Direct regulation of HOXA11 by miR-30d and 181a. 293T cells were transfected with luciferase reporter plasmid containing 30-UTR of
HOXA11, together with miRNA mimic, anti-miRNA or negative controls. MiR-30d or 181a overexpression significantly decreased the relative lucifer-
ase activity of the wild-type 30-UTR but not the mutant 30-UTR in which these two miRNA-binding sites were deleted (A). Conversely, knockdown of
miR-30d or 181a significantly increased the relative luciferase activity (B). Each experiment was conducted in triplicate. Quantitative data represent-
ing the mean  SD are presented in the bar graph. *P < 0.01 compared with negative controls.
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HOXA11 mRNA expression. One of possible mechanisms is that
HOXA11 can be also controlled by other miRNAs. Indeed, biocompu-
tational prediction algorithms found approximately ten miRNAs
potentially targeting HOXA11 mRNA. Instead of assessing all of them,
we performed further study only for two miRNAs (miR-30d and 181a)
that were overexpressed in the microarray. The coordinate action of
several miRNAs may be involved in the HOXA11 deficient signalling in
the USLs of POP patients, and this needs to be evaluated in future
studies. In addition, these data were derived from in vitro cultured
293T cells, which may not reflect complex regulatory interactions
in vivo. Indeed, pelvic floor fibroblasts express estrogen receptors
[28], and the estrogen-estrogen receptor (ER) complex is known to
directly bind to regulatory elements of HOXA11 and induce its expres-
sion [29]. Therefore, dysregulation of miRNAs that target ER may
affect HOXA11 expression in vivo. It has been shown that ERa protein
expression is significantly reduced in both premenopausal and post-
menopausal patients with POP [30, 31]. Among the eighteen miRNAs
that were overexpressed in the microarray described in the present
study, miR-222 is known to regulate ERa expression at the posttrans-
lational level [32]. While this work was in progress, Shi et al. also
found that miR-222 expression is increased in the USLs of women
with POP compared to normal counterparts and that there is an
inverse correlation between ERa protein and miR-222 expression
[33]. In conclusion, based on Shi et al.’s study and ours, the data
suggest that the cooperative activity of dysregulated miRNAs may
contribute to the deficient HOXA11 signalling in the USLs associated
with POP. In this regards, the combined treatment of estradiol and
anti-miR-222 along with anti-miR-30d or 181a may further increase
the expression of HOXA11 protein compared with anti-miR-30d or
181a alone. This needs to be evaluated and confirmed in further
study.
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